Fundraising Fox

INVO Bioscience

NASDAQ: IVF

Sarasota, US · Nevada corporation

Healthtech

Founders & leadership

MC
Michael CampbellChief Operating Officer and VP of Business Development
AGAndrea Goren
Andrea GoreninChief Financial Officer
SS
Steven ShumChief Executive Officer

Board

TD
Trent DavisBoard director
MS
Matthew SzotBoard director
BR
Barbara RyanBoard director
RM
Rebecca MessinaBoard director

Reported raises · per SEC filings

Form D private placements

$7.3M disclosed across 5 rounds · 2018–2023

▶$3MraisedApr 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CampbellExecutive Officer
  • Andrea GorenExecutive Officer
  • Trent DavisDirector
  • Steven ShumExecutive Officer, Director
  • Matthew SzotDirector
  • Barbara RyanDirector
  • Rebecca MessinaDirector
Offering amount
$3M
Amount sold
$3M
Sales commissions
$148.8K
Proceeds to insiders
$130K
Placement agents
MAXIM GROUP LLC
First sale
Mar 2023
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rebecca MessinaDirector
  • Steven ShumExecutive Officer, Director
  • Andrea GorenExecutive Officer
  • Barbara RyanDirector
  • Jeffrey SegalDirector
  • Trent DavisDirector
  • Michael CampbellExecutive Officer
  • Matthew SzotDirector
Offering amount
$500K
Amount sold
$500K
Sales commissions
$36K
Proceeds to insiders
$10K
Placement agents
Carter, Terry & Company, Inc.
First sale
Feb 2023
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$275KraisedJan 2023 · 7 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Andrea GorenExecutive Officer
  • Barbara RyanDirector
  • Jeffrey SegalDirector
  • Rebecca MessinaDirector
  • Steven ShumExecutive Officer, Director
  • Trent DavisDirector
  • Michael CampbellExecutive Officer
  • Matthew SzotDirector
Offering amount
$3.5M
Amount sold
$275K
Proceeds to insiders
$10K
First sale
Jan 2023
Incorporated
Corporation, Nevada
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$3.5MraisedJul 2020 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Trent DavisDirector
  • Steven ShumExecutive Officer, Director
  • Debra HoopesExecutive Officer
  • Kevin DoodyDirector
  • Kathleen T. KarloffDirector
  • Michael J. CampbellExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$3.5M
Minimum investment
$25K
Sales commissions
$236K
Placement agents
Roth Capital, LLC, Tribal Capital Markets LLC
First sale
May 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15KraisedJan 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven T ShumDirector
  • Michael J. CampbellDirector
  • Robert J BowdringDirector
  • Kevin DoodyDirector
  • Kathleen T KarloffExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$15K
Minimum investment
$5K
Proceeds to insiders
$80K
First sale
Jan 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

INVO Bioscience Inc stock (US44984F1049): fertility player updates investors after financing movead-hoc-news.de · May 2026INVO Bioscience stock (US44984F1049): merger story, Nasdaq relisting and fertility-tech ambitionsad-hoc-news.de · May 2026INVO, NAYA Call Off Merger After Six Months — Fertility Bridgefertilitybridge.com · May 2025

Frequently asked questions

How much funding has INVO Bioscience raised?
INVO Bioscience has disclosed $7.3M raised across 5 rounds.
Where is INVO Bioscience headquartered?
INVO Bioscience is headquartered in Sarasota, US.